Shares of Envista Holdings Co. (NYSE:NVST – Get Free Report) have been given a consensus rating of “Hold” by the fifteen brokerages that are covering the firm, MarketBeat reports. Three analysts have rated the stock with a sell recommendation, nine have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $19.63.
NVST has been the subject of a number of research reports. Bank of America cut their target price on shares of Envista from $22.00 to $19.00 and set a “buy” rating for the company in a research note on Thursday, August 8th. Evercore ISI raised their price objective on shares of Envista from $18.00 to $23.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. Robert W. Baird decreased their target price on Envista from $19.00 to $17.00 and set a “neutral” rating on the stock in a research report on Monday, July 22nd. JPMorgan Chase & Co. cut Envista from an “overweight” rating to a “neutral” rating and dropped their price target for the stock from $23.00 to $16.00 in a report on Thursday, August 8th. Finally, Piper Sandler reduced their price target on Envista from $18.00 to $16.00 and set a “neutral” rating for the company in a research note on Tuesday, July 30th.
Check Out Our Latest Report on Envista
Insider Buying and Selling at Envista
Institutional Inflows and Outflows
Several hedge funds have recently made changes to their positions in the business. American International Group Inc. increased its stake in shares of Envista by 0.3% in the 4th quarter. American International Group Inc. now owns 231,461 shares of the company’s stock valued at $5,569,000 after acquiring an additional 650 shares in the last quarter. Vanguard Group Inc. increased its stake in Envista by 5.8% in the fourth quarter. Vanguard Group Inc. now owns 17,167,767 shares of the company’s stock valued at $413,056,000 after purchasing an additional 944,596 shares in the last quarter. PNC Financial Services Group Inc. raised its holdings in shares of Envista by 271.2% during the fourth quarter. PNC Financial Services Group Inc. now owns 24,123 shares of the company’s stock valued at $580,000 after purchasing an additional 17,624 shares during the period. Quadrature Capital Ltd bought a new position in shares of Envista during the 4th quarter worth about $787,000. Finally, NBC Securities Inc. grew its stake in shares of Envista by 60.6% in the 1st quarter. NBC Securities Inc. now owns 8,879 shares of the company’s stock valued at $189,000 after buying an additional 3,351 shares during the period.
Envista Trading Down 0.8 %
Shares of Envista stock opened at $17.70 on Wednesday. The stock has a market cap of $3.04 billion, a P/E ratio of -24.58 and a beta of 1.32. The company has a quick ratio of 1.90, a current ratio of 2.22 and a debt-to-equity ratio of 0.47. Envista has a 12-month low of $15.15 and a 12-month high of $25.64. The business’s 50 day moving average is $18.17 and its 200-day moving average is $18.15.
Envista (NYSE:NVST – Get Free Report) last released its quarterly earnings data on Wednesday, August 7th. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.27 by ($0.16). Envista had a positive return on equity of 4.86% and a negative net margin of 52.25%. The firm had revenue of $633.10 million for the quarter, compared to analyst estimates of $646.88 million. During the same quarter in the prior year, the firm earned $0.43 earnings per share. The firm’s revenue for the quarter was down 4.4% on a year-over-year basis. Equities research analysts predict that Envista will post 0.69 earnings per share for the current fiscal year.
About Envista
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
See Also
- Five stocks we like better than Envista
- Are Penny Stocks a Good Fit for Your Portfolio?
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- Stock Market Upgrades: What Are They?
- AMD Gains Momentum With AI: Can It Beat Expectations?
- What Are Dividend Achievers? An Introduction
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.